UVDI-360 room sanitizer inactivates SARS-CoV-2 at 12 feet (3.65 meters) distance in 5 minutes
UV-C Disinfecting Device Used in Hospitals Globally Achieves 99.99% Inactivation of SARS-CoV-2 in BSL-3 Laboratory Testing
VALENCIA, Calif. — UltraViolet Devices, Inc. (UVDI) announced its UVDI-360 room sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).
Testing on the coronavirus strain that causes the COVID-19 disease was conducted by Innovative Bioanalysis, a CAP, CLIA, and BEI-recognized BSL-3 certified laboratory (CA, USA).
The Centers for Disease Control and Prevention (CDC) has indicated that the COVID-19 disease can be spread by both surface and airborne transmission of SARS-CoV-2.1
The testing parameters were carefully selected to be indicative of rapid whole room disinfection in hospitals.
The UVDI-360 Room Sanitizer has previously been proven to help prevent Healthcare-Associated Infections and to inactivate over 35 pathogens, including human coronavirus (229E), in over 10 peer-reviewed published clinical studies and independent laboratory testing.
“We hope this important testing can lend confidence and comfort to Healthcare professionals working bravely and tirelessly to beat COVID-19,” stated Peter Veloz, chief executive officer, UVDI.
“Specific to use in hospitals for whole room disinfection, we believe that proving rapid inactivation of pathogens at distances of 8 feet (2.44 meters) and 12 feet (3.65 meters) is the best marker for in-facility performance. Independent confirmation of effectiveness against high-risk pathogens is a common sense, yet critical step to verify disinfecting claims for UV devices,” said Veloz.
“Building on our deep science-based evidence demonstrating the UVDI-360’s effectiveness against high-risk pathogens, including coronaviruses, we feel the healthcare professionals we serve globally deserve proof against the specific SARS-CoV-2 viral strain causing COVID-19,” added Dr. Ashish Mathur, vice president of Innovation and Technology, UVDI.
Last Updated on 3 years by Editor – PK
